1. ALLA AKTIER
  2. NYHETER
  3. LIPUM

Lipum

Nyheter Lipum Nyheter alla bolag

Lipum AB – interim report for the period July-September 2023

MARKN.

Lipum AB (publ) has published the interim report for period July to September for 2023. Below is a summary, a complete report (only in Swedish) is available on the company's website.

CEO Einar Pontén comments: “The multiple dosing of healthy subjects in our ongoing Phase 1 clinical trial was started according to plan.”

Financial summary January - September 2023

  • Net sales: KSEK 0 (0)
  • Result after financial items: KSEK -27 727 (-25 068)
  • Cash and cash equivalents as of September 30: KSEK 17 551 (9 482)

Significant events during the period July - September 2023

  • Capital contribution from rights issue 15.3 MSEK before overheads of 8%.
  • Collaboration with researchers at Karolinska Institutet initiated.
  • Publication of a scientific article on BSSL.

Significant events after the period

  • Lipum's Phase 1 clinical trial advanced to multiple dosing and all eight subjects received their first dose.

CEO Einar Pontén comments on the report in a live webcast on October 31 at 09:00, link.

Contacts
Einar Pontén, CEO
einar.ponten@lipum.se
+46 70 578 34 95
Web: www.lipum.se

About Us
Lipum AB (publ) is a clinical stage biopharmaceutical company specialized in discovery and development of a novel treatment for chronic inflammatory diseases. The lead candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule of the immune system (BSSL). SOL-116 is in clinical stage supported by solid data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need. The company is based in Umeå, an excellent life science cluster in Sweden. Lipum’s unique approach has attracted international attention, including a major European Commission Horizon 2020 grant. The company's share (LIPUM) is traded on the Nasdaq First North Growth Market. Certified Adviser is G&W Fondkommission.

Attachments
Lipum AB Kvartalsrapport Juli September 2023

Datum 2023-10-31, kl 08:00
Källa MFN
Bifogade filer
Lipum AB Kvartalsrapport Juli September 2023
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!